Alina Schneider1, Michael G Crabb1, Carlos Velasco1, Karl P Kunze1,2, Radhouene Neji1,2, René M Botnar1,3, and Claudia Prieto1,3
1School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom, 2MR Research Collaborations, Siemens Healthcare Limited, Camberley, United Kingdom, 3Institute for Biological and Medical Engineering, Pontificia Universidad Católica de Chile, Santiago, Chile
Synopsis
Keywords: Quantitative Imaging, Cardiovascular
Simultaneously acquired 18F-FDG
PET-MR imaging and quantitative 2D T
1 and T
2 mapping have
been suggested for improved diagnostic accuracy of cardiac sarcoidosis, however
misregistration between imaging modalities and sequential MR scans makes
clinical interpretation challenging. Here we evaluate the feasibility of
recently proposed 3D joint T
1/T
2 sequence at a 3T PET-MR
system. This approach enables non-rigid motion-correction for both the 3D T
1/T
2
mapping and the PET data to the same respiratory position, resulting in aligned
volumes for improved clinical interpretation. In this proof-of-concept study,
we tested our approach in a phantom and two healthy subjects.
Introduction
Clinical
guidelines for the diagnosis of cardiac sarcoidosis (CS) currently suggest a combined
approach using a number of different investigations, including late gadolinium
enhancement (LGE) cardiac MR (CMR) and 18F-fluorodeoxyglucose (18F-FDG)
positron emission tomography (PET) in addition to biopsy1. For improved diagnosis,
simultaneously acquired 18F-FDG PET-MR imaging and quantitative T1
and T2 mapping2,3
have been suggested, however,
respiratory motion related mis-registration between conventional cardiac MR
data, usually acquired in 2D under multiple breath holds, and simultaneously
acquired 3D free-breathing PET data remains a challenge when interpreting
imaging findings, thus hindering clinical adoption. Moreover, respiratory
motion degrades both image quality and quantification of PET and MR images.
To
overcome these challenges, we propose a highly efficient, motion-compensated
comprehensive PET-MR framework for cardiac sarcoidosis, providing myocardial tissue
characterization from novel 3D joint T1/T2 MR parametric
maps as well as non-rigid respiratory motion fields to
correct simultaneously acquired PET data4 in a 3T hybrid
PET-MR system. In this
proof-of-concept study, we evaluate the proposed joint T1/T2
mapping sequence in a phantom and two healthy subjects. Methods
Acquisition
& Reconstruction: An
ECG-triggered free-breathing 3D whole-heart joint T1/T2 research
sequence was implemented on a 3T PET-MR system (Biograph mMR, Siemens Healthcare,
Erlangen, Germany) (Figure 1). Four interleaved volumes are acquired using two point
Dixon GRE readout and a 4-fold undersampled variable-density Cartesian
trajectory5. The sequence includes four interleaves with 1) Inversion
Recovery (IR) preparation, 2) and 3) no-preparation, 4) T2-preparation
(T2prep) respectively6. Image navigators (iNAVs)7 are integrated in the sequence to enable 100% respiratory
scan efficiency and predictable scan time. 3D non-rigid motion is estimated and
incorporated into a motion-compensated reconstruction8 with patch-based low-rank regularization9 to produce motion-compensated datasets. A water-fat
separation algorithm10 is used to generate water and fat
images for each dataset, and the water images are used to obtain the signal
evolution across the acquired volumes. T1 and
T2 maps are then computed using dictionary-matching with a
dictionary generated using an EPG simulation11.
Imaging & Analysis: A phantom and
two healthy subjects were scanned on a 3T PET-MR scanner using the proposed approach.
Data was acquired during mid-diastole (acquisition window = 92±15ms). MR
imaging parameters included: coronal orientation, FOV=320x320x120mm3,
2mm3 isotropic resolution, T2 prep=40ms, TI=250ms, TE1/TE2/TR=2.30/3.75/5.42ms,
flip angle=15°, acquisition time ~ 6min. Conventional breath-held 2D T1 and T2
maps were also acquired in short axis orientation at apical, mid-cavity and basal
slices for comparison purposes (imaging parameters 2D T2 mapping:
resolution = 1.5x1.5x8mm3, T2-preparation pulses = 0, 28,
55 ms, flip angle=12°; imaging parameters 2D T1 mapping: resolution
= 1.4x1.4x8mm3, TI = 100ms, flip angle=35°). ROI was selected at the septum, where mean and standard deviation were calculated for both subjects.Results
Joint T1/T2
maps of the phantom in comparison to
conventional maps acquired clinically and reference values from12 are shown in Figure 2 and
Figure 3, where comparable values between the proposed technique and the
conventional method and reference values for both T1 (R2=0.983,
R2=0.985) and T2 maps (R2=0.974, R2=0.99) are observed. T1 and T2
maps alongside water and fat images for both healthy volunteers are shown in Figure
4. T1 and T2 maps from the proposed joint T1/T2
approach are shown in Figure 5, along with the conventional
2D T1 and 2D T2 reference maps obtained during the same
examination for a healthy subject. Values for 3D approach were: T1=1330.7286ms,
T2=38.9447ms, compared to values obtained with the 2D approach: T1=1315.1429,
T2=39.26ms.Conclusion
Preliminary
results of the proposed joint T1/T2
mapping at 3T hybrid PET-MR system, that allows
acquisition of isotropic T1 and T2 maps and complimentary
co-registered water/fat anatomical datasets, demonstrate the feasibility of this
technique. Further studies in a larger cohort of healthy subjects and patients
with cardiac sarcoidosis undergoing a PET/MR scan are warranted. Acknowledgements
This
work was supported by the following grants: (1) EP/L015226/1, EPSRC
P/V044087/1; (2) BHF programme grant RG/20/1/34802, (3) Wellcome/EPSRC Centre
for Medical Engineering (WT 203148/Z/16/Z), (4) Millennium Institute for
Intelligent Healthcare Engineering ICN2021_004, (5) FONDECYT 1210637 and
1210638, (6) IMPACT, Center of Interventional Medicine for Precision and
Advanced Cellular Therapy, ANID FB210024.References
1. Birnie, D. H. et al. HRS expert
consensus statement on the diagnosis and management of arrhythmias associated
with cardiac sarcoidosis. Hear. Rhythm 11, 1305–23 (2014).
2. Crouser, E. D., Ono, C., Tran, T., He, X. & Raman, S. V.
Improved detection of cardiac sarcoidosis using magnetic resonance with
myocardial T2 mapping. Am. J. Respir. Crit. Care Med. 189, 109–12
(2014).
3. Cheung, E. et al. Combined simultaneous FDG-PET/MRI
with T1 and T2 mapping as an imaging biomarker
for the diagnosis and prognosis of suspected cardiac sarcoidosis. Eur.
J. hybrid imaging 5, 24 (2021).
4. Munoz, C. et al. Motion‐corrected simultaneous cardiac
positron emission tomography and coronary MR angiography with high acquisition
efficiency. Magn. Reson. Med. 79, 339 (2018).
5. Prieto, C. et al. Highly efficient respiratory motion
compensated free-breathing coronary mra using golden-step Cartesian
acquisition. J. Magn. Reson. Imaging 41, 738–746 (2015).
6. Milotta, G. et al. 3D whole-heart isotropic-resolution
motion-compensated joint T(1) /T(2) mapping
and water/fat imaging. Magn. Reson. Med. 84, 3009–3026
(2020).
7. Henningsson, M. et al. Whole-heart coronary MR
angiography with 2D self-navigated image reconstruction. Magn. Reson. Med.
67, 437–445 (2012).
8. Batchelor, P. G. et al. Matrix description of general
motion correction applied to multishot images. Magn. Reson. Med. 54,
1273–1280 (2005).
9. Bustin, A. et al. Accelerated free-breathing whole-heart
3D T2 mapping with high isotropic resolution. Magn. Reson. Med. 83,
988–1002 (2019).
10. Liu, J., Peters, D. C. & Drangova, M.
Method of B0 mapping with magnitude-based correction for bipolar two-point
Dixon cardiac MRI. Magn. Reson. Med. 78, 1862–1869 (2017).
11. Weigel, M. Extended phase graphs:
Dephasing, RF pulses, and echoes - pure and simple. J. Magn. Reson. Imaging
41, 266–295 (2015).
12. Captur, G. et al. A medical
device-grade T1 and ECV phantom for global T1 mapping quality assurance—the T1
Mapping and ECV Standardization in cardiovascular magnetic resonance (T1MES)
program. J. Cardiovasc. Magn. Reson. 18, 58 (2016).